HC Wainwright & Co. Maintains Buy on Biomea Fusion, Raises Price Target to $50
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Joseph Pantginis maintains a Buy rating on Biomea Fusion (NASDAQ:BMEA) and raises the price target from $37 to $50.
June 26, 2023 | 10:20 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. maintains a Buy rating on Biomea Fusion (NASDAQ:BMEA) and raises the price target from $37 to $50.
The raised price target by HC Wainwright & Co. indicates a positive outlook for Biomea Fusion's stock. This news is likely to be perceived positively by investors, potentially leading to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100